Epidemiology and Molecular Pathology of Gallbladder Cancer

Gallbladder cancer is usually associated with gallstone disease, late diagnosis, unsatisfactory treatment, and poor prognosis. We report here the worldwide geographical distribution of gallbladder cancer, review the main etiologic hypotheses, and provide some comments on perspectives for prevention. The highest incidence rate of gallbladder cancer is found among populations of the Andean area, North American Indians, and Mexican Americans. Gallbladder cancer is up to three times higher among women than men in all populations. The highest incidence rates in Europe are found in Poland, the Czech Republic, and Slovakia. Incidence rates in other regions of the world are relatively low. The highest mortality rates are also reported from South America, 3.5–15.5 per 100,000 among Chilean Mapuche Indians, Bolivians, and Chilean Hispanics. Intermediate rates, 3.7 to 9.1 per 100,000, are reported from Peru, Ecuador, Colombia, and Brazil. Mortality rates are low in North America, with the exception of high rates among American Indians in New Mexico (11.3 per 100,000) and among Mexican Americans.

[1]  M. Trevisan,et al.  Diet, physical activity, and gallstones--a population-based, case-control study in southern Italy. , 1999, The American journal of clinical nutrition.

[2]  H. Watanabe,et al.  Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  J. Araya,et al.  DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  H. Watanabe,et al.  p53 Immunostaining distinguishes malignant from benign lesions of the gall‐bladder , 1995, Pathology international.

[5]  E. Rimm,et al.  Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. , 1999, Alcoholism, clinical and experimental research.

[6]  S. Tominaga,et al.  A Case‐Control Study of Biliary Tract Cancer in Niigata Prefecture, Japan , 1989, Japanese journal of cancer research : Gann.

[7]  M. Fujino,et al.  Ultrasonographic evidence of association of polyps and stones with gallbladder cancer , 1999, American Journal of Gastroenterology.

[8]  O. Yokosuka,et al.  Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing , 1990, Cancer.

[9]  K. Hatakeyama,et al.  Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. , 1996, Surgery.

[10]  M. Pike,et al.  From gene to carcinogen: a rapidly evolving field in molecular epidemiology. , 1991, Cancer research.

[11]  F. Paraf,et al.  [Are industrial toxic substances a risk factor in gallbladder cancer?]. , 1990, Gastroenterologie clinique et biologique.

[12]  Yusuke Nakamura,et al.  APC, K‐ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall‐bladder suggest two genetic pathways in gall‐bladder carcinogenesis , 1996, Pathology international.

[13]  J. Araya,et al.  Gallbladder cancer in a high risk area: morphological features and spread patterns. , 1999, Hepato-gastroenterology.

[14]  K. Hanada,et al.  TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns. , 1997, European journal of cancer.

[15]  A. Muratore,et al.  Radical surgery for gallbladder cancer: current options. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  F. Fabián,et al.  [The importance of early cholecystectomy in cholelithiasis for the prevention of carcinoma of the gallbladder]. , 1989, Bratislavske lekarske listy.

[17]  G. Everson,et al.  Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. , 1982, Gastroenterology.

[18]  Y. Nimura,et al.  Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation. , 1996, The American journal of gastroenterology.

[19]  F. Nervi,et al.  Increasing gall‐bladder cancer mortality rate during the last decade in Chile, a high‐risk area , 1990, International journal of cancer.

[20]  R. Herrera-Goepfert,et al.  The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ , 1980, Cancer.

[21]  C. Wilder.  HOSPITAL DISCHARGES AND LENGTH OF STAY: SHORT‐STAY HOSPITALS, UNITED STATES, JULY 1963–JUNE 1964 , 1966, Vital and health statistics. Series 10, Data from the National Health Survey.

[22]  A. Diehl.  Epidemiology of gallbladder cancer: a synthesis of recent data. , 1980, Journal of the National Cancer Institute.

[23]  H. Yokozaki,et al.  High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  L. Melton,et al.  Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. , 1987, Annals of internal medicine.

[25]  D. Petitti,et al.  Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. , 1981, The New England journal of medicine.

[26]  D. Henson,et al.  Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates , 1992, Cancer.

[27]  C. la Vecchia,et al.  Risk factors for gallbladder cancer: A polish case‐control study , 1992, International journal of cancer.

[28]  S. D. Lee,et al.  Age is one of the risk factors in developing gallstone disease in Taiwan. , 1998, Age and ageing.

[29]  M. Hill,et al.  Cancer mortality in chronic typhoid and paratyphoid carriers , 1994, The Lancet.

[30]  M. Savolainen,et al.  Polymorphisms at the apoB , apoA-1 , and cholesteryl ester transfer protein gene loci in patients with gallbladder disease , 2002 .

[31]  A. Calvo,et al.  Biliary‐tract cancer in Chile , 1990, International journal of cancer.

[32]  H. Adami,et al.  Parity and cancers of the gall bladder and the extrahepatic bile ducts , 1993, International journal of cancer.

[33]  W. Linden.  Genetic Factors in Gallstone Disease , 1973 .

[34]  K. Mohandas,et al.  Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[35]  J. Araya,et al.  Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. , 1996, Gastroenterology.

[36]  A. Wenckert,et al.  The natural course of gallstone disease: eleven-year review of 781 nonoperated cases. , 1966, Gastroenterology.

[37]  横山 直行.  Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile , 1999 .

[38]  K. Höckerstedt,et al.  Poor prognosis of gallbladder cancer persists regardless of improved diagnostic methods. Incidence and results of surgery during 20 years in Helsinki. , 1997, Annales chirurgiae et gynaecologiae.

[39]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[40]  K. Pohlandt.  [Gallbladder carcinoma]. , 1960, Munchener medizinische Wochenschrift.

[41]  M. Teh,et al.  Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. , 1994, Journal of clinical pathology.

[42]  B. Warren,et al.  Carcinoma of the gallbladder--a possible regional predisposition in the western Cape and northern Cape. , 1995, South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie.

[43]  E. Rimm,et al.  A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. , 1999, JAMA.

[44]  S. Maeda,et al.  p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. , 1996, Hepato-gastroenterology.

[45]  J. Everhart.  Contributions of Obesity and Weight Loss to Gallstone Disease , 1993, Annals of Internal Medicine.

[46]  W J Schull,et al.  Individual admixture estimates: disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas. , 1986, American journal of physical anthropology.

[47]  Y. Soini,et al.  p53 and c‐erbB‐2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder , 1993, The Journal of pathology.

[48]  C. Key,et al.  Carcinoma of the gallbladder in a population of Southwestern American Indians , 1977, Cancer.

[49]  P. Baghurst,et al.  Diet, alcohol, and relative weight in gall stone disease: a case-control study. , 1984, British medical journal.

[50]  M. Carey,et al.  Pathogenesis of cholesterol gallstones: a parsimonious hypothesis , 1996, European journal of clinical investigation.

[51]  D. Ransohoff,et al.  Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. , 1983, Annals of internal medicine.

[52]  S. Darby,et al.  Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia , 1993, The Lancet.

[53]  D. Burkitt,et al.  Some diseases characteristic of modern Western civilization. , 1973, British medical journal.

[54]  E. A. Graham.  THE PREVENTION OF CARCINOMA OF THE GALL‐BLADDER , 1931, Annals of surgery.

[55]  I. Wistuba,et al.  Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. , 1999, Human pathology.

[56]  M. Ebara,et al.  Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. , 1985, Gastroenterology.

[57]  T. Itoi,et al.  Correlation of p53 protein expression with gene mutation in gall‐bladder carcinomas , 1997, Pathology international.

[58]  I. Wistuba,et al.  p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. , 1996, Human pathology.

[59]  T. Jørgensen.  [Treatment of gallstones]. , 1999, Ugeskrift for laeger.

[60]  P. Coursaget,et al.  Vaccination against infectious agents associated with human cancer , 1999 .

[61]  K. Washington,et al.  Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. , 2008, Liver.

[62]  F. Nervi,et al.  [Beta glucuronidase activity in Salmonella typhi and paratyphi]. , 1988, Revista medica de Chile.

[63]  I. Wistuba,et al.  Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. , 1995, Cancer research.

[64]  E. Rimm,et al.  The Relation of Physical Activity to Risk for Symptomatic Gallstone Disease in Men , 1998, Annals of Internal Medicine.

[65]  R. Laraja,et al.  Elective cholecystectomy and carcinoma of the gallbladder. , 1991, The American surgeon.

[66]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[67]  L. Naldi,et al.  An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. , 1995, Journal of clinical epidemiology.

[68]  W. H. Kim,et al.  Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[69]  A. McMichael,et al.  Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study. , 1984 .

[70]  G. Thériault,et al.  Retrospective cohort study of workers of a synthetic textiles plant in Quebec: I. General mortality. , 1994, American journal of industrial medicine.

[71]  A. Klein-Szanto,et al.  Proliferative potential and K‐ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union , 1998 .

[72]  C. la Vecchia,et al.  Family history and the risk of liver, gallbladder, and pancreatic cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[73]  F. Nervi,et al.  Frequency of gallbladder cancer in chile, A high‐risk area , 1988, International journal of cancer.

[74]  B. Modan,et al.  Cholelithiasis in the aetiology of gallbladder neoplasms. , 1971, Lancet.

[75]  A. Zimmermann,et al.  p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival , 1995, Hepatology.

[76]  P. Lavin,et al.  Gallbladder adenocarcinoma: The prognostic significance of histologic grade , 1987, Journal of surgical oncology.

[77]  Tomokazu Hoshi,et al.  K‐ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis , 1994, Cancer.

[78]  L. Sobin,et al.  The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition , 1992, Cancer.

[79]  A. Diehl.  Gallstone size and the risk of gallbladder cancer. , 1983, JAMA.

[80]  S. Kono,et al.  Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men , 1999, International Journal of Obesity.

[81]  B. Modan,et al.  CHOLELITHIASIS IN THE ÆTIOLOGY OF GALLBLADDER NEOPLASMS , 1971 .

[82]  M. Pandey,et al.  Salmonella carrier state, chronic bacterial infection and gallbladder carcinogenesis. , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[83]  I. Kott,et al.  Carcinoma in situ of the gallbladder. , 1974, Medecine & chirurgie digestives.

[84]  L. Heilbrun,et al.  Natural history study of gallbladder cancer. A review of 36 years experience at M. D. Anderson hospital and tumor institute , 1978, Cancer.

[85]  J. J. Bonilla,et al.  Gallstone disease in high-altitude peruvian rural populations , 1999, American Journal of Gastroenterology.

[86]  D. Henson,et al.  Liver, gallbladder, extrahepatic bile ducts, and pancreas , 1995, Cancer.

[87]  J. Ahlberg,et al.  Decreasing frequency of cholecystectomies in the counties of Stockholm and Uppsala, Sweden. , 1978, Acta chirurgica Scandinavica. Supplementum.

[88]  K. Hanada,et al.  K‐ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct , 1996, Cancer.

[89]  Soon C. Lee,et al.  p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater , 1995, Pathology.

[90]  花田 敬士.  K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct , 1996 .

[91]  R. Feldman,et al.  The Risk Ratio Is Insufficient for Clinical Decisions , 1984, Medical decision making : an international journal of the Society for Medical Decision Making.

[92]  W. Willett,et al.  Weight, diet, and the risk of symptomatic gallstones in middle-aged women. , 1989, The New England journal of medicine.

[93]  S. Maeda,et al.  K-ras gene mutation in gall bladder carcinomas and dysplasia. , 1996, Gut.

[94]  F. Carballo,et al.  Prevalence and associated factors for gallstone disease: results of a population survey in Spain. , 1997, Journal of clinical epidemiology.

[95]  A. Wee,et al.  An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas , 1994, Cancer.

[96]  S. Haffner,et al.  High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. , 1997, Archives of medical research.

[97]  A. Qizilbash,et al.  Biliary neoplasia in Gardner's syndrome. , 1987, Archives of pathology & laboratory medicine.

[98]  A. Lazaris,et al.  Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gallbladder cancer. , 1996, Pathology, research and practice.

[99]  J. F. Jr,et al.  Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas , 1999, British Journal of Cancer.

[100]  M. Ochiai,et al.  K‐ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction , 1996, Cancer.

[101]  J. Baillargeon,et al.  A population-based case-control study of cancer of the bile ducts and gallbladder in Quebec, Canada. , 1993, Revue d'epidemiologie et de sante publique.

[102]  H. P. Wang,et al.  Anomalous pancreaticobiliary ductal union--an etiologic association of gallbladder cancer and adenomyomatosis. , 1998, Hepato-gastroenterology.

[103]  J. Araya,et al.  p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma , 1997, Histopathology.

[104]  S. Báez,et al.  Risk factors for gallbladder cancer. An international collaborative case-control study. , 1996, Cancer.

[105]  A. Blanken.  Hospital discharges and length of stay: short-stay hospitals. United States-1972. , 1976, Vital and health statistics. Series 10, Data from the National Health Survey.

[106]  A. Klein-Szanto,et al.  Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. , 1998, Cancer.

[107]  A. Lowenfels.  DOES BILE PROMOTE EXTRA-COLONIC CANCER? , 1978, The Lancet.

[108]  Harbans Singh,et al.  Chronic typhoid carriage and carcinoma of the gallbladder. , 1997, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[109]  M. Ochiai,et al.  K‐ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction , 2022 .

[110]  V. Beral,et al.  CHOLECYSTECTOMY AND CHANGING MORTALITY FROM GALLBLADDER CANCER , 1981, The Lancet.

[111]  D. Henson,et al.  Carcinoma in situ of the gallbladder: A clinicopathologic study of 18 cases , 1984, The American journal of surgical pathology.

[112]  R. Kominami,et al.  Mutation of the p53 gene in gallbladder cancer. , 1994, The Tohoku journal of experimental medicine.

[113]  K. Miyazaki,et al.  Spontaneous apoptosis in gallbladder carcinoma: Relationships with clinicopathologic factors, expression of E‐cadherin, bcl‐2 protooncogene, and p53 oncosuppressor gene , 1996, Cancer.

[114]  J. Miquel,et al.  Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. , 1998, Gastroenterology.

[115]  A. Menotti,et al.  Factors associated with gallstone disease in the MICOL experience , 1997, Hepatology.

[116]  R. Badea,et al.  Risk of asymptomatic and symptomatic gallstones in moderately obese women: a longitudinal follow-up study. , 1997, The American journal of gastroenterology.

[117]  M. Hill,et al.  The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[118]  H. Shimada,et al.  Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones. , 1989, The American journal of gastroenterology.

[119]  B. Modan,et al.  Epidemiological aspects of gallbladder and biliary tract neoplasm. , 1972, American journal of public health.

[120]  K. Inui,et al.  Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. , 1997, Hepato-gastroenterology.

[121]  P. Boyle,et al.  Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. , 1997, Journal of the National Cancer Institute.

[122]  A. Neugut,et al.  Risk factors for biliary tract cancers , 1999, American Journal of Gastroenterology.

[123]  J. Albores–Saavedra,et al.  Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma. , 1999, Journal of hepato-biliary-pancreatic surgery.